[Renal manifestations in rheumatic diseases].
Inflammatory rheumatic diseases other than systemic vasculitides and systemic lupus erythematosus are frequently associated with renal abnormalities, which are clinically less apparent due to the subtle course and the often only moderate impairment of renal function. These abnormalities include vascular, glomerular and tubulointerstitial changes. Renal manifestations in the course of rheumatoid arthritis influence the prognosis of the disease. Renal involvement due to AA amyloidosis following long-standing inflammatory joint disease can lead slowly, over years, to end-stage renal disease. A scleroderma renal crisis in the course of systemic sclerosis can potentially result in end-stage renal disease within days. The differential diagnosis of renal abnormalities in a rheumatic patient should include drug induced renal impairment as well as infection.
de Groot
K
K
Med. Klinik III (Nephrologie, Hypertensiologie, Rheumatologie), Klinikum Offenbach GmbH, 63069 Offenbach. kirsten@de-groot.de
D000686:Amyloidosis / Q000175:diagnosis / Q000473:pathology; D003937:Diagnosis, Differential; D005922:Glomerulonephritis, IGA / Q000175:diagnosis / Q000473:pathology; D015432:Glomerulonephritis, Membranoproliferative / Q000175:diagnosis / Q000473:pathology; D006801:Humans; D007674:Kidney Diseases / Q000175:diagnosis* / Q000473:pathology; D007676:Kidney Failure, Chronic / Q000175:diagnosis* / Q000473:pathology; D007677:Kidney Function Tests; D007678:Kidney Glomerulus / Q000473:pathology; D012077:Renal Artery / Q000473:pathology; D012216:Rheumatic Diseases / Q000150:complications / Q000175:diagnosis* / Q000473:pathology; D012595:Scleroderma, Systemic / Q000175:diagnosis / Q000473:pathology; D000685:Serum Amyloid A Protein / Q000378:metabolism; D014527:Uric Acid / Q000097:blood
D000685:Serum Amyloid A Protein; D014527:Uric Acid